{"id":21500,"date":"2021-09-10T10:49:13","date_gmt":"2021-09-10T14:49:13","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=21500"},"modified":"2021-09-10T10:49:13","modified_gmt":"2021-09-10T14:49:13","slug":"new-filings-updated-terms-week-ending-09-10-21am","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-week-ending-09-10-21am\/","title":{"rendered":"New Filings &#038; Updated Terms (Week ending 09.10.21am)"},"content":{"rendered":"<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p>Company: Cingulate, Inc.<br \/>\nSymbol: CING (Nasdaq)<br \/>\nDescription: They are a clinical stage biopharmaceutical company using our proprietary Precision Timed Release, or PTR, drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Oppenheimer<br \/>\nCo-Manager(s): Ladenburg Thalmann, Brookline Capital<br \/>\nLink to Prospectus: Filed: 09-9-21<br \/>\nListed Cash Raise: $57.5m<\/p>\n<p>Company: TCDX, Inc.<br \/>\nSymbol: TCDX<br \/>\nDescription: They are a high-growth digital customer experience solutions provider for innovative technology and other blue-chip companies.<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Goldman Sachs, Credit Suisse<br \/>\nLink to Prospectus: Filed: 09-7-21<br \/>\nListed Cash Raise: $400m<\/p>\n<p>Company: First Watch Restaurant Group, Inc.<br \/>\nSymbol: FWRG (Nasdaq)<br \/>\nDescription: They are an award-winning daytime restaurant concept serving made-to-order breakfast, brunch and lunch using fresh ingredients.<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: BofA Securities, Goldman Sachs, Jefferies, Barclays, Citigroup, Piper Sandler, Cowen, Guggenheim Securities, Stifel<br \/>\nLink to Prospectus: Filed: 09-7-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Allvue Systems Holdings Inc.<br \/>\nSymbol: ALVU<br \/>\nDescription: Allvue sets a new standard in technology for investment managers in the private capital and credit markets by pairing modern cloud-based software solutions with capabilities across multiple asset classes.<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Goldman Sachs, Barclays, Credit Suisse, Deutsche Bank, RBC Capital, Truist Securities<br \/>\nCo-Manager(s): Piper Sandler, Stifel, Cabrera Capital Markets, CastleOak Securities, C.L. King &amp; Associates, Mischler Financial Group, Telsey Advisory Group<br \/>\nLink to Prospectus: Filed: 09-3-21<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>TERMS ADDED<\/strong><\/span><\/p>\n<p>Company: DICE Therapeutics Inc<br \/>\nSymbol: DICE (Nasdaq)<br \/>\nDescription: They are a biopharmaceutical company leveraging our proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas.<br \/>\nShares: 10 million<br \/>\nPrice Range: $15.00-$17.00<br \/>\nMarket Cap: $515m-$583m<br \/>\nTrade Date: Wednesday, 9\/15<br \/>\nUnderwriters: BofA Securities, SVB Leerink, Evercore ISI<br \/>\nLink to Prospectus: Terms Added: 9-9-21<\/p>\n<p>Company: Tyra Biosciences, Inc.<br \/>\nSymbol: TYRA (Nasdaq)<br \/>\nDescription: They are a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.<br \/>\nShares: 6.7 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nMarket Cap: $515m-$589m<br \/>\nTrade Date: Wednesday, 9\/15<br \/>\nUnderwriters: BofA Securities, Jefferies, Cowen<br \/>\nLink to Prospectus: Terms Added: 9-9-21<\/p>\n<p>Company: PROCEPT BioRobotics Corporation<br \/>\nSymbol: PRCT (Nasdaq)<br \/>\nDescription: They are a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology.<br \/>\nShares: 5.5 million<br \/>\nPrice Range: $22.00-$24.00<br \/>\nMarket Cap: $907m-$989m<br \/>\nTrade Date: Wednesday, 9\/15<br \/>\nUnderwriters: BofA Securities, Goldman Sachs<br \/>\nCo-manager(s): Cowen, Guggenheim Securities, SVB Leerink<br \/>\nLink to Prospectus: Terms Added: 9-8-21<\/p>\n<p>Company: Definitive Healthcare Corp<br \/>\nSymbol: DH (Nasdaq)<br \/>\nDescription: Definitive Healthcare is a leading provider of healthcare commercial intelligence.<br \/>\nShares: 15.5 million<br \/>\nPrice Range: $21.00-$24.00<br \/>\nMarket Cap: $3.1b-3.55b<br \/>\nTrade Date: Wednesday, 9\/15<br \/>\nUnderwriters: Goldman Sachs, J.P. Morgan, Morgan Stanley, Barclays, Credit Suisse, Deutsche Bank Securities<br \/>\nCo-Manager(s): Canaccord Genuity, Raymond James, Stifel, Drexel Hamilton, Loop Capital<br \/>\nLink to Prospectus: Terms Added: 9-7-21<\/p>\n<p>Company: Thoughtworks Holding, Inc.<br \/>\nSymbol: TWKS (Nasdaq)<br \/>\nDescription: They are a leading premium global technology consultancy that integrates strategy, design and software engineering to enable enterprises and technology disruptors across the globe to thrive as modern digital businesses.<br \/>\nShares: 36.84 million<br \/>\nPrice Range: $18.00-$20.00<br \/>\nMarket Cap: $5.5b-$6.1b<br \/>\nTrade Date: Wednesday, 9\/15<br \/>\nUnderwriters: Goldmans Sachs, J.P. Morgan, Credit Suisse, BofA Securities, Citigroup, RBC Capital, HSBC<br \/>\nCo-Manager(s): Baird, Cowen, Nomura, Piper Sandler, Wedbush Securities, William Blair, CastleOak Securities, Mischler Financial Group, Sieber Williams Shank<br \/>\nLink to Prospectus: Terms Added:9-7-21<\/p>\n<p>Company: Sportradar Group AG<br \/>\nSymbol: SRAD (Nasdaq)<br \/>\nDescription: Sportradar is a leading technology platform enabling next generation engagement in sports, and the number one provider of business-to-business (\u201cB2B\u201d) solutions to the global sports betting industry based on revenue.<br \/>\nShares: 19 million<br \/>\nPrice Range: $25.00-$28.00<br \/>\nMarket Cap: $7.4b- 8.3b<br \/>\nTrade Date: Tuesday, 9\/14<br \/>\nUnderwriters: JP Morgan, Morgan Stanley, Citigroup, UBS Investment Bank, BofA Securities, Deutsche Bank Securities, Jefferies, Canaccord Genuity<br \/>\nCo-manager(s): Needham, Benchmark, Craig-Hallum, Siebert Williams Shank, Telsey Advisory Group<br \/>\nLink to Prospectus: Terms Added:9-7-21<\/p>\n<p>Company: ForgeRock, Inc.<br \/>\nSymbol: FORG (NYSE)<br \/>\nDescription: ForgeRock supports billions of identities to help people simply and safely access the connected world\u2014from shopping and banking to accessing company networks to get their work done.<br \/>\nShares: 11 million<br \/>\nPrice Range: $21.00-$24.00<br \/>\nMarket Cap: $1.7b-$1.9b<br \/>\nTrade Date: Thursday, 9\/16<br \/>\nUnderwriters: Morgan Stanley, J.P. Morgan, Deutsche Bank, Mizuho Securities, HSBC<br \/>\nCo-Manager(s): BTIG, Cowen, Piper Sandler, Truist Securities, William Blair<br \/>\nLink to Prospectus: Terms Added:9-7-21<\/p>\n<p>Company: On Holding AG<br \/>\nSymbol: ONON (NYSE)<br \/>\nDescription: On is a premium performance sports brand rooted in technology, design and impact that has built a passionate global community of fans across more than 60 countries.<br \/>\nShares: 31.1 million<br \/>\nPrice Range: $18.00-$20.00<br \/>\nMarket Cap: $5.5b-$6.1b<br \/>\nTrade Date: Wednesday, 9\/15<br \/>\nUnderwriters: Goldman Sachs, Morgan Stanley, J.P. Morgan, Allen &amp; Company, UBS Investment Bank, Credit Suisse<br \/>\nLink to Prospectus: Terms Added:9-7-21<\/p>\n<p>Company: Dutch Bros Inc.<br \/>\nSymbol: BROS (NYSE)<br \/>\nDescription: Dutch Bros is a high growth operator and franchisor of drive-thru shops that focus on serving high QUALITY, hand-crafted beverages with unparalleled SPEED and superior SERVICE.<br \/>\nShares: 21.052 million<br \/>\nPrice Range: $18.00-$20.00<br \/>\nMarket Cap: $3.0b-$3.3b<br \/>\nTrade Date: Wednesday, 9\/15<br \/>\nUnderwriters: BofA Securities, J.P. Morgan, Jefferies, Barclays, Piper Sandler, Baird, William Blair<br \/>\nCo-Manager(s): Cowen, Stifel, AmeriVet Securities, Penserra Securities LLC R. Seelaus &amp; Co., Tribal Capital Markets<br \/>\nLink to Prospectus: Terms Added:9-7-21<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW FILINGS Company: Cingulate, Inc. Symbol: CING (Nasdaq) Description: They are a clinical stage biopharmaceutical company using our proprietary Precision Timed Release, or PTR, drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing[&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-21500","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/21500","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=21500"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/21500\/revisions"}],"predecessor-version":[{"id":21501,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/21500\/revisions\/21501"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=21500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=21500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=21500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}